+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Fistula Drug"

Anal Fistula Treatment - Global Strategic Business Report - Product Thumbnail Image

Anal Fistula Treatment - Global Strategic Business Report

  • Report
  • May 2024
  • 194 Pages
  • Global
From
Anal Fistula - Pipeline Insight, 2024 - Product Thumbnail Image

Anal Fistula - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Digestive System Fistula - Pipeline Insight, 2024 - Product Thumbnail Image

Digestive System Fistula - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
From
From
From
Anal Fistula - Epidemiology Forecast to 2032 - Product Thumbnail Image

Anal Fistula - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Digestive System Fistula - Epidemiology Forecast - 2032 - Product Thumbnail Image

Digestive System Fistula - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
From
From
  • 13 Results (Page 1 of 1)
Loading Indicator

The Fistula Drug market is a subset of the Gastrointestinal Drugs market, which includes drugs used to treat diseases and disorders of the digestive system. Fistula Drugs are used to treat fistulas, which are abnormal connections between two organs or between an organ and the skin. These drugs are used to reduce inflammation, reduce pain, and promote healing. Commonly used Fistula Drugs include corticosteroids, antibiotics, and immunosuppressants. Fistula Drugs are typically administered orally, intravenously, or topically. The market for Fistula Drugs is expected to grow due to the increasing prevalence of fistulas and the need for effective treatments. Some companies in the Fistula Drug market include AbbVie, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, Pfizer, and Sanofi. Show Less Read more